Pancreatic cancer biology and genetics (original) (raw)

• Niederhuber, J. E., Brennan, M. F. & Menck, H. R. The National Cancer Data Base report on pancreatic cancer. Cancer 76, 1671–1677 (1995).
  Article CAS PubMed Google Scholar
• Warshaw, A. L. & Fernandez-del Castillo, C. Pancreatic carcinoma. N. Engl. J. Med. 326, 455–465 (1992).
  Article CAS PubMed Google Scholar
• Ahrendt, S. A. & Pitt, H. A. Surgical management of pancreatic cancer. Oncology 16, 725–734; discussion 734, 736–738, 740, 743 (2002).
  PubMed Google Scholar
• Kern, S. et al. A white paper: the product of a pancreas cancer think tank. Cancer Res. 61, 4923–4932 (2001).
  CAS PubMed Google Scholar
• Anderson, K. E., Potter, J. D. & Mack, T. M. in Cancer Epidemiology and Prevention (eds Schottenfeld, D. & Fraumeni, J. J.) 725–771 (Oxford University Press, New York, 1996).
  Google Scholar
• Lynch, H. T. et al. Familial pancreatic cancer: a review. Semin. Oncol. 23, 251–275 (1996).
  CAS PubMed Google Scholar
• Jaffee, E. M., Hruban, R. H., Canto, M. & Kern, S. E. Focus on pancreas cancer. Cancer Cell 2, 25–28 (2002).
  Article CAS PubMed Google Scholar
• Eberle, M. A. et al. A new susceptibility locus for autosomal dominant pancreatic cancer maps to chromosome 4q32-34. Am. J. Hum. Genet. 70, 1044–1048 (2002). Linkage mapping of a new familial pancreatic cancer gene.
  Article CAS PubMed PubMed Central Google Scholar
• Lowenfels, A. B. et al. Hereditary pancreatitis and the risk of pancreatic cancer. International Hereditary Pancreatitis Study Group. J. Natl Cancer Inst. 89, 442–446 (1997).
  Article CAS PubMed Google Scholar
• Whitcomb, D. C. et al. Hereditary pancreatitis is caused by a mutation in the cationic trypsinogen gene. Nature Genet. 14, 141–145 (1996).
  Article CAS PubMed Google Scholar
• Kinzler, K. W. & Vogelstein, B. Lessons from hereditary colorectal cancer. Cell 87, 159–170 (1996).
  Article CAS PubMed Google Scholar
• Cubilla, A. L. & Fitzgerald, P. J. Morphological lesions associated with human primary invasive nonendocrine pancreas cancer. Cancer Res. 36, 2690–2698 (1976). A landmark study providing histological evidence for a ductal cell of origin for pancreatic adenocarcinoma.
  CAS PubMed Google Scholar
• Klimstra, D. S. & Longnecker, D. S. K-ras mutations in pancreatic ductal proliferative lesions. Am. J. Pathol. 145, 1547–1550 (1994).
  CAS PubMed PubMed Central Google Scholar
• Hruban, R. H. et al. Pancreatic intraepithelial neoplasia: a new nomenclature and classification system for pancreatic duct lesions. Am. J. Surg. Pathol. 25, 579–586 (2001).
  Article CAS PubMed Google Scholar
• Klein, W. M., Hruban, R. H., Klein-Szanto, A. J. & Wilentz, R. E. Direct correlation between proliferative activity and dysplasia in pancreatic intraepithelial neoplasia (PanIN): additional evidence for a recently proposed model of progression. Mod. Pathol. 15, 441–447 (2002).
  Article PubMed Google Scholar
• Moskaluk, C. A., Hruban, R. H. & Kern, S. E. p16 and K-ras gene mutations in the intraductal precursors of human pancreatic adenocarcinoma. Cancer Res. 57, 2140–2143 (1997).
  CAS PubMed Google Scholar
• Yamano, M. et al. Genetic progression and divergence in pancreatic carcinoma. Am. J. Pathol. 156, 2123–2133 (2000).
  Article CAS PubMed PubMed Central Google Scholar
• Luttges, J. et al. Allelic loss is often the first hit in the biallelic inactivation of the p53 and DPC4 genes during pancreatic carcinogenesis. Am. J. Pathol. 158, 1677–1683 (2001). References 16–18 document common mutational profiles in PanINs and pancreatic adenocarcinomas occurring in the same patient, providing genetic evidence that PanINs are progenitors of adenocarcinomas.
  Article CAS PubMed PubMed Central Google Scholar
• Wilentz, R. E. et al. Loss of expression of Dpc4 in pancreatic intraepithelial neoplasia: evidence that DPC4 inactivation occurs late in neoplastic progression. Cancer Res. 60, 2002–2006 (2000).
  CAS PubMed Google Scholar
• Heinmoller, E. et al. Molecular analysis of microdissected tumors and preneoplastic intraductal lesions in pancreatic carcinoma. Am. J. Pathol. 157, 83–92 (2000).
  Article CAS PubMed PubMed Central Google Scholar
• Rozenblum, E. et al. Tumor-suppressive pathways in pancreatic carcinoma. Cancer Res. 57, 1731–1734 (1997). Mutational profile of a large series of pancreatic adenocarcinomas.
  CAS PubMed Google Scholar
• Biankin, A. V. et al. Overexpression of p21(WAF1/CIP1) is an early event in the development of pancreatic intraepithelial neoplasia. Cancer Res. 61, 8830–8837 (2001).
  CAS PubMed Google Scholar
• Shields, J. M., Pruitt, K., McFall, A., Shaub, A. & Der, C. J. Understanding Ras: 'it ain't over 'til it's over'. Trends Cell Biol. 10, 147–154 (2000).
  Article CAS PubMed Google Scholar
• Korc, M. et al. Overexpression of the epidermal growth factor receptor in human pancreatic cancer is associated with concomitant increases in the levels of epidermal growth factor and transforming growth factor alpha. J. Clin. Invest. 90, 1352–1360 (1992).
  Article CAS PubMed PubMed Central Google Scholar
• Barton, C. M., Hall, P. A., Hughes, C. M., Gullick, W. J. & Lemoine, N. R. Transforming growth factor alpha and epidermal growth factor in human pancreatic cancer. J. Pathol. 163, 111–116 (1991).
  Article CAS PubMed Google Scholar
• Friess, H. et al. Pancreatic cancer: the potential clinical relevance of alterations in growth factors and their receptors. J. Mol. Med. 74, 35–42 (1996).
  Article CAS PubMed Google Scholar
• Watanabe, M., Nobuta, A., Tanaka, J. & Asaka, M. An effect of K-ras gene mutation on epidermal growth factor receptor signal transduction in PANC-1 pancreatic carcinoma cells. Int. J. Cancer 67, 264–268 (1996).
  Article CAS PubMed Google Scholar
• Sibilia, M. et al. The EGF receptor provides an essential survival signal for SOS-dependent skin tumor development. Cell 102, 211–220 (2000).
  Article CAS PubMed Google Scholar
• Day, J. D. et al. Immunohistochemical evaluation of HER-2/ neu expression in pancreatic adenocarcinoma and pancreatic intraepithelial neoplasms. Hum. Pathol. 27, 119–124 (1996).
  Article CAS PubMed Google Scholar
• Wagner, M. et al. Expression of a truncated EGF receptor is associated with inhibition of pancreatic cancer cell growth and enhanced sensitivity to cisplatinum. Int. J. Cancer 68, 782–787 (1996).
  Article CAS PubMed Google Scholar
• Overholser, J. P., Prewett, M. C., Hooper, A. T., Waksal, H. W. & Hicklin, D. J. Epidermal growth factor receptor blockade by antibody IMC-C225 inhibits growth of a human pancreatic carcinoma xenograft in nude mice. Cancer 89, 74–82 (2000).
  Article CAS PubMed Google Scholar
• Whelan, A. J., Bartsch, D. & Goodfellow, P. J. Brief report: a familial syndrome of pancreatic cancer and melanoma with a mutation in the CDKN2 tumor-suppressor gene. N. Engl. J. Med. 333, 975–977 (1995).
  Article CAS PubMed Google Scholar
• Goldstein, A. M. et al. Increased risk of pancreatic cancer in melanoma-prone kindreds with p16INK4 mutations. N. Engl. J. Med. 333, 970–974 (1995).
  Article CAS PubMed Google Scholar
• Goldstein, A. M., Struewing, J. P., Chidambaram, A., Fraser, M. C. & Tucker, M. A. Genotype-phenotype relationships in U. S. melanoma-prone families with CDKN2A and CDK4 mutations. J. Natl Cancer Inst. 92, 1006–1010 (2000).
  Article CAS PubMed Google Scholar
• Lynch, H. T. et al. Phenotypic variation in eight extended CDKN2A germline mutation familial atypical multiple mole melanoma-pancreatic carcinoma-prone families: the familial atypical mole melanoma-pancreatic carcinoma syndrome. Cancer 94, 84–96 (2002).
  Article CAS PubMed Google Scholar
• Borg, A. et al. High frequency of multiple melanomas and breast and pancreas carcinomas in CDKN2A mutation-positive melanoma families. J. Natl Cancer Inst. 92, 1260–1266 (2000).
  Article CAS PubMed Google Scholar
• Sherr, C. J. The INK4A/ARF network in tumour suppression. Nature Rev. Mol. Cell Biol. 2, 731–737 (2001).
  Article CAS Google Scholar
• Liu, L. et al. Mutation of the CDKN2A 5′ UTR creates an aberrant initiation codon and predisposes to melanoma. Nature Genet. 21, 128–132 (1999).
  Article PubMed CAS Google Scholar
• Lal, G. et al. Patients with both pancreatic adenocarcinoma and melanoma may harbor germline CDKN2A mutations. Genes Chromosom. Cancer 27, 358–361 (2000).
  Article CAS PubMed Google Scholar
• Krimpenfort, P., Quon, K. C., Mooi, W. J., Loonstra, A. & Berns, A. Loss of p16Ink4a confers susceptibility to metastatic melanoma in mice. Nature 413, 83–86 (2001).
  Article CAS PubMed Google Scholar
• Sharpless, N. E. et al. Loss of p16Ink4a with retention of p19Arf predisposes mice to tumorigenesis. Nature 413, 86–91 (2001). References 40 and 41 report the phenotypes of Ink4a-knockout mice.
  Article CAS PubMed Google Scholar
• Zindy, F., Quelle, D. E., Roussel, M. F. & Sherr, C. J. Expression of the p16INK4a tumor suppressor versus other INK4 family members during mouse development and aging. Oncogene 15, 203–211 (1997).
  Article CAS PubMed Google Scholar
• Nielsen, G. P. et al. Immunohistochemical survey of p16INK4A expression in normal human adult and infant tissues. Lab. Invest. 79, 1137–1143 (1999).
  CAS PubMed Google Scholar
• Sherr, C. J. & DePinho, R. A. Cellular senescence: mitotic clock or culture shock? Cell 102, 407–410 (2000).
  Article CAS PubMed Google Scholar
• Ramirez, R. D. et al. Putative telomere-independent mechanisms of replicative aging reflect inadequate growth conditions. Genes Dev. 15, 398–403 (2001).
  Article CAS PubMed PubMed Central Google Scholar
• Schmitt, C. A. et al. A senescence program controlled by p53 and p16(INK4a) contributes to the outcome of cancer therapy. Cell 109, 335–346 (2002).
  Article CAS PubMed Google Scholar
• Zhu, J., Woods, D., McMahon, M. & Bishop, J. M. Senescence of human fibroblasts induced by oncogenic Raf. Genes Dev. 12, 2997–3007 (1998).
  Article CAS PubMed PubMed Central Google Scholar
• Brookes, S. et al. INK4A-deficient human diploid fibroblasts are resistant to RAS-induced senescence. EMBO J. 21, 2936–2945 (2002).
  Article CAS PubMed PubMed Central Google Scholar
• Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D. & Lowe, S. W. Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell 88, 593–602 (1997). References 47–49 provide an explanation for the oncogenic cooperation of activated RAS genes and loss of the INK4A /ARF locus.
  Article CAS PubMed Google Scholar
• Luttges, J. et al. The K-ras mutation pattern in pancreatic ductal adenocarcinoma usually is identical to that in associated normal, hyperplastic, and metaplastic ductal epithelium. Cancer 85, 1703–1710 (1999).
  Article CAS PubMed Google Scholar
• Laghi, L. et al. Common occurrence of multiple K-RAS mutations in pancreatic cancers with associated precursor lesions and in biliary cancers. Oncogene 21, 4301–4306 (2002).
  Article CAS PubMed Google Scholar
• Jackson, E. L. et al. Analysis of lung tumor initiation and progression using conditional expression of oncogenic K-ras. Genes Dev. 15, 3243–3248 (2001).
  Article CAS PubMed PubMed Central Google Scholar
• Chin, L. et al. Cooperative effects of INK4A and RAS in melanoma susceptibility in vivo. Genes Dev. 11, 2822–2834 (1997).
  Article CAS PubMed PubMed Central Google Scholar
• Fisher, G. H. et al. Induction and apoptotic regression of lung adenocarcinomas by regulation of a K-Ras transgene in the presence and absence of tumor suppressor genes. Genes Dev. 15, 3249–3262 (2001).
  Article CAS PubMed PubMed Central Google Scholar
• Sharpless, N. E. & DePinho, R. A. The INK4A/ARF locus and its two gene products. Curr. Opin. Genet. Dev. 9, 22–30 (1999).
  Article CAS PubMed Google Scholar
• Maser, R. S. & DePinho, R. A. Connecting chromosomes, crisis, and cancer. Science 297, 565–569 (2002).
  Article CAS PubMed Google Scholar
• Gorunova, L. et al. Cytogenetic analysis of pancreatic carcinomas: intratumor heterogeneity and nonrandom pattern of chromosome aberrations. Genes Chromosom. Cancer 23, 81–99 (1998).
  Article CAS PubMed Google Scholar
• Artandi, S. E. et al. Telomere dysfunction promotes non-reciprocal translocations and epithelial cancers in mice. Nature 406, 641–645 (2000).
  Article CAS PubMed Google Scholar
• Chin, L. et al. p53 deficiency rescues the adverse effects of telomere loss and cooperates with telomere dysfunction to accelerate carcinogenesis. Cell 97, 527–538 (1999).
  Article CAS PubMed Google Scholar
• Gisselsson, D. et al. Chromosomal breakage-fusion-bridge events cause genetic intratumor heterogeneity. Proc. Natl Acad. Sci. USA 97, 5357–5362 (2000).
  Article CAS PubMed PubMed Central Google Scholar
• Gisselsson, D. et al. Telomere dysfunction triggers extensive DNA fragmentation and evolution of complex chromosome abnormalities in human malignant tumors. Proc. Natl Acad. Sci. USA 98, 12683–12688 (2001). Evidence for a role of telomere attrition in promoting chromosomal instability in the progression of pancreatic adenocarcinoma.
  Article CAS PubMed PubMed Central Google Scholar
• Suehara, N. et al. Telomerase elevation in pancreatic ductal carcinoma compared to nonmalignant pathological states. Clin. Cancer Res. 3, 993–998 (1997).
  CAS PubMed Google Scholar
• Venkitaraman, A. R. Cancer susceptibility and the functions of BRCA1 and BRCA2. Cell 108, 171–182 (2002).
  Article CAS PubMed Google Scholar
• Cancer risks in BRCA2 mutation carriers. The Breast Cancer Linkage Consortium. J. Natl Cancer Inst. 91, 1310–1316 (1999).
• Goggins, M., Hruban, R. H. & Kern, S. E. BRCA2 is inactivated late in the development of pancreatic intraepithelial neoplasia: evidence and implications. Am. J. Pathol. 156, 1767–1771 (2000).
  Article CAS PubMed PubMed Central Google Scholar
• Sato, N. et al. Correlation between centrosome abnormalities and chromosomal instability in human pancreatic cancer cells. Cancer Genet. Cytogenet. 126, 13–19 (2001).
  Article CAS PubMed Google Scholar
• Aarnio, M., Mecklin, J. P., Aaltonen, L. A., Nystrom-Lahti, M. & Jarvinen, H. J. Life-time risk of different cancers in hereditary non-polyposis colorectal cancer (HNPCC) syndrome. Int. J. Cancer 64, 430–433 (1995).
  Article CAS PubMed Google Scholar
• Goggins, M. et al. Pancreatic adenocarcinomas with DNA replication errors (RER+) are associated with wild-type K-ras and characteristic histopathology. Poor differentiation, a syncytial growth pattern, and pushing borders suggest RER+. Am. J. Pathol. 152, 1501–1507 (1998).
  CAS PubMed PubMed Central Google Scholar
• Mahlamaki, E. H. et al. Comparative genomic hybridization reveals frequent gains of 20q, 8q, 11q, 12p, and 17q, and losses of 18q, 9p, and 15q in pancreatic cancer. Genes Chromosom. Cancer 20, 383–391 (1997).
  Article CAS PubMed Google Scholar
• Peltomaki, P. & de la Chapelle, A. Mutations predisposing to hereditary nonpolyposis colorectal cancer. Adv. Cancer Res. 71, 93–119 (1997).
  Article CAS PubMed Google Scholar
• Lynch, H. T., Voorhees, G. J., Lanspa, S. J., McGreevy, P. S. & Lynch, J. F. Pancreatic carcinoma and hereditary nonpolyposis colorectal cancer: a family study. Br. J. Cancer 52, 271–273 (1985).
  Article CAS PubMed PubMed Central Google Scholar
• Yamamoto, H. et al. Genetic and clinical features of human pancreatic ductal adenocarcinomas with widespread microsatellite instability. Cancer Res. 61, 3139–3144 (2001).
  CAS PubMed Google Scholar
• Wilentz, R. E. et al. Genetic, immunohistochemical, and clinical features of medullary carcinoma of the pancreas: a newly described and characterized entity. Am. J. Pathol. 156, 1641–1651 (2000).
  Article CAS PubMed PubMed Central Google Scholar
• Hahn, S. A. et al. DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1. Science 271, 350–353 (1996). Identification of SMAD4/DPC4.
  Article CAS PubMed Google Scholar
• Massague, J., Blain, S. W. & Lo, R. S. TGF-β signaling in growth control, cancer, and heritable disorders. Cell 103, 295–309 (2000).
  Article CAS PubMed Google Scholar
• Sirard, C. et al. Targeted disruption in murine cells reveals variable requirement for Smad4 in transforming growth factor beta-related signaling. J. Biol. Chem. 275, 2063–2070 (2000).
  Article CAS PubMed Google Scholar
• Jonson, T. et al. Altered expression of TGF-β receptors and mitogenic effects of TGF-β in pancreatic carcinomas. Int. J. Oncol. 19, 71–81 (2001).
  CAS PubMed Google Scholar
• Dai, J. L. et al. Transforming growth factor-beta responsiveness in DPC4/SMAD4-null cancer cells. Mol. Carcinog. 26, 37–43 (1999).
  Article CAS PubMed Google Scholar
• Giehl, K., Seidel, B., Gierschik, P., Adler, G. & Menke, A. TGF-β1 represses proliferation of pancreatic carcinoma cells which correlates with Smad4-independent inhibition of ERK activation. Oncogene 19, 4531–4541 (2000).
  Article CAS PubMed Google Scholar
• Rowland-Goldsmith, M. A., Maruyama, H., Kusama, T., Ralli, S. & Korc, M. Soluble type II transforming growth factor-beta (TGF-beta) receptor inhibits TGF-beta signaling in COLO-357 pancreatic cancer cells in vitro and attenuates tumor formation. Clin. Cancer Res. 7, 2931–2940 (2001).
  CAS PubMed Google Scholar
• Hemminki, A. et al. A serine/threonine kinase gene defective in Peutz–Jeghers syndrome. Nature 391, 184–187 (1998).
  Article CAS PubMed Google Scholar
• Solcia, E., Capella, C. & Kloppel, G. Tumors of the Pancreas (ed. Rosai, J.) (Armed Forces Institute for Pathology, Washington DC, 1995).
  Google Scholar
• Pour, P. M. The role of langerhans islets in pancreatic ductal adenocarcinoma. Front Biosci. 2, d271–282 (1997).
  Article CAS PubMed Google Scholar
• Boardman, L. A. et al. Genetic heterogeneity in Peutz–Jeghers syndrome. Hum. Mutat. 16, 23–30 (2000).
  Article CAS PubMed Google Scholar
• Cooper, H. S. in Pathology of the Gastrointestinal Tract (eds Ming, S.-C. & Goldman, H.) 819–853 (Wiliams & Wilkens, Baltimore, 1998).
  Google Scholar
• Olschwang, S. et al. Peutz–Jeghers disease: most, but not all, families are compatible with linkage to 19p13.3. J. Med. Genet. 35, 42–44 (1998).
  Article CAS PubMed PubMed Central Google Scholar
• Olschwang, S., Boisson, C. & Thomas, G. Peutz–Jeghers families unlinked to STK11/LKB1 gene mutations are highly predisposed to primitive biliary adenocarcinoma. J. Med. Genet. 38, 356–360 (2001).
  Article CAS PubMed PubMed Central Google Scholar
• Klimstra, D. S. in Pancreatic Cancer: Advances in Molecular Pathology, Diagnosis and Clinical Management (eds Sarkar, F. S. & Duggan, M. C.) 21–48 (Eaton Publishing, Natick, Massachusetts, 1998).
  Google Scholar
• Jimenez, R. E. et al. Immunohistochemical characterization of pancreatic tumors induced by dimethylbenzanthracene in rats. Am. J. Pathol. 154, 1223–1229 (1999).
  Article CAS PubMed PubMed Central Google Scholar
• Wagner, M. et al. A murine tumor progression model for pancreatic cancer recapitulating the genetic alterations of the human disease. Genes Dev. 15, 286–293 (2001). The first description of a genetically defined mouse model of pancreatic adenocarcinoma.
  Article CAS PubMed PubMed Central Google Scholar
• Yoshida, T. & Hanahan, D. Murine pancreatic ductal adenocarcinoma produced by in vitro transduction of polyoma middle T oncogene into the islets of Langerhans. Am. J. Pathol. 145, 671–684 (1994).
  CAS PubMed PubMed Central Google Scholar
• Tosh, D. & Slack, J. M. How cells change their phenotype. Nature Rev. Mol. Cell Biol. 3, 187–194 (2002).
  Article CAS Google Scholar
• Blau, H. M., Brazelton, T. R. & Weimann, J. M. The evolving concept of a stem cell: entity or function? Cell 105, 829–841 (2001).
  Article CAS PubMed Google Scholar
• Bonner–Weir, S. & Sharma, A. Pancreatic stem cells. J. Pathol. 197, 519–526 (2002).
  Article PubMed Google Scholar
• Elsasser, H.-P., Adler, G. & Kern, H. F. in The Pancreas: Biology, Pathobiology and Disease (Raven Press Ltd, New York, 1993).
  Google Scholar
• Bonner–Weir, S., Stubbs, M., Reitz, P., Taneja, M. & Smith, F. E. in Pancreatic Growth and Regeneration (ed. Sarvetnick, N.) (Karger Landes Systems, Basel, Switzerland, 1997).
  Google Scholar
• Sharma, A. et al. The homeodomain protein IDX-1 increases after an early burst of proliferation during pancreatic regeneration. Diabetes 48, 507–513 (1999).
  Article CAS PubMed Google Scholar
• Vinik, A. I., Pittenger, G. L., Rafaeloff, R., Rosenberg, L. & Duguid, W. in Pancreatic Growth and Regeneration. (ed. Sarvetnick, N.) 183–217 (Karger Landes Systems, Basel, 1997).
  Google Scholar
• Scoggins, C. R. et al. p53-dependent acinar cell apoptosis triggers epithelial proliferation in duct-ligated murine pancreas. Am. J. Physiol. Gastrointest. Liver Physiol. 279, G827–G836 (2000).
  Article CAS PubMed Google Scholar
• Kritzik, M. R. et al. PDX-1 and Msx-2 expression in the regenerating and developing pancreas. J. Endocrinol. 163, 523–530 (1999).
  Article CAS PubMed Google Scholar
• Arnush, M. et al. Growth factors in the regenerating pancreas of γ-interferon transgenic mice. Lab. Invest. 74, 985–990 (1996).
  CAS PubMed Google Scholar
• Rooman, I., Heremans, Y., Heimberg, H. & Bouwens, L. Modulation of rat pancreatic acinoductal transdifferentiation and expression of PDX-1 in vitro. Diabetologia 43, 907–914 (2000).
  Article CAS PubMed Google Scholar
• Bachoo, R. M. et al. Epidermal growth factor receptor and Ink4a/Arf. Convergent mechanisms governing terminal differentiation and transformation along the neural stem cell to astrocyte axis. Cancer Cell 1, 269–277 (2002).
  Article CAS PubMed Google Scholar
• Lohr, M. et al. Transforming growth factor-β1 induces desmoplasia in an experimental model of human pancreatic carcinoma. Cancer Res. 61, 550–555 (2001).
  CAS PubMed Google Scholar
• Schwarte-Waldhoff, I. et al. Smad4/DPC4-mediated tumor suppression through suppression of angiogenesis. Proc. Natl Acad. Sci. USA 97, 9624–9629 (2000).
  Article CAS PubMed PubMed Central Google Scholar
• Bissell, M. J. & Radisky, D. Putting tumours in context. Nature Rev. Cancer 1, 46–54 (2001).
  CAS Google Scholar
• Olumi, A. F. et al. Carcinoma-associated fibroblasts direct tumor progression of initiated human prostatic epithelium. Cancer Res. 59, 5002–5011 (1999).
  CAS PubMed Google Scholar
• Van Dyke, T. & Jacks, T. Cancer modeling in the modern era: progress and challenges. Cell 108, 135–144 (2002).
  Article CAS PubMed Google Scholar
• Ornitz, D. M., Hammer, R. E., Messing, A., Palmiter, R. D. & Brinster, R. L. Pancreatic neoplasia induced by SV40 T-antigen expression in acinar cells of transgenic mice. Science 238, 188–193 (1987).
  Article CAS PubMed Google Scholar
• Glasner, S., Memoli, V. & Longnecker, D. S. Characterization of the ELSV transgenic mouse model of pancreatic carcinoma. Histologic type of large and small tumors. Am. J. Pathol. 140, 1237–1245 (1992).
  CAS PubMed PubMed Central Google Scholar
• Quaife, C. J., Pinkert, C. A., Ornitz, D. M., Palmiter, R. D. & Brinster, R. L. Pancreatic neoplasia induced by Ras expression in acinar cells of transgenic mice. Cell 48, 1023–1034 (1987).
  Article CAS PubMed Google Scholar
• Sandgren, E. P., Quaife, C. J., Paulovich, A. G., Palmiter, R. D. & Brinster, R. L. Pancreatic tumor pathogenesis reflects the causative genetic lesion. Proc Natl Acad Sci USA 88, 93–97 (1991).
  Article CAS PubMed PubMed Central Google Scholar
• Sandgren, E. P. et al. Transforming growth factor alpha dramatically enhances oncogene-induced carcinogenesis in transgenic mouse pancreas and liver. Mol. Cell Biol. 13, 320–330 (1993).
  CAS PubMed PubMed Central Google Scholar
• Bardeesy, N. et al. Obligate roles for p16(Ink4a) and p19(Arf)-p53 in the suppression of murine pancreatic neoplasia. Mol. Cell Biol. 22, 635–643 (2002).
  Article CAS PubMed PubMed Central Google Scholar
• Sotillo, R. et al. Wide spectrum of tumors in knock-in mice carrying a Cdk4 protein insensitive to INK4 inhibitors. EMBO J. 20, 6637–6647 (2001).
  Article CAS PubMed PubMed Central Google Scholar
• Rane, S. G. et al. Loss of Cdk4 expression causes insulin-deficient diabetes and Cdk4 activation results in β-islet cell hyperplasia. Nature Genet. 22, 44–52 (1999).
  Article CAS PubMed Google Scholar
• Xu, X. et al. Haploid loss of the tumor suppressor Smad4/Dpc4 initiates gastric polyposis and cancer in mice. Oncogene 19, 1868–1874 (2000).
  Article CAS PubMed Google Scholar
• Takaku, K. et al. Gastric and duodenal polyps in Smad4 (Dpc4) knockout mice. Cancer Res. 59, 6113–6117 (1999).
  CAS PubMed Google Scholar
• Jishage, K. et al. Role of Lkb1, the causative gene of Peutz–Jegher's syndrome, in embryogenesis and polyposis. Proc. Natl Acad. Sci. USA 99, 8903–8908 (2002).
  Article CAS PubMed PubMed Central Google Scholar
• Miyoshi, H. et al. Gastrointestinal hamartomatous polyposis in Lkb1 heterozygous knockout mice. Cancer Res. 62, 2261–2266 (2002).
  CAS PubMed Google Scholar
• Bardeesy, N. et al. Loss of the Lkb1 tumour suppressor provokes intestinal polyposis but resistance to transformation. Nature 419, 162–167 (2002).
  Article CAS PubMed Google Scholar
• Robanus-Maandag, E. et al. p107 is a suppressor of retinoblastoma development in pRb-deficient mice. Genes Dev. 12, 1599–1609 (1998).
  Article CAS PubMed PubMed Central Google Scholar
• Jonkers, J. & Berns, A. Conditional mouse models of sporadic cancer. Nature Rev. Cancer 2, 251–265 (2002).
  Article CAS Google Scholar
• Gu, G., Dubauskaite, J. & Melton, D. A. Direct evidence for the pancreatic lineage: NGN3+ cells are islet progenitors and are distinct from duct progenitors. Development 129, 2447–2457 (2002).
  Article CAS PubMed Google Scholar
• Chin, L. et al. Essential role for oncogenic Ras in tumour maintenance. Nature 400, 468–472 (1999).
  Article CAS PubMed Google Scholar
• Hennig, R. et al. 5-lipoxygenase and leukotriene b(4) receptor are expressed in human pancreatic cancers but not in pancreatic ducts in normal tissue. Am. J. Pathol. 161, 421–428 (2002).
  Article CAS PubMed PubMed Central Google Scholar
• Maitra, A. et al. Cyclooxygenase 2 expression in pancreatic adenocarcinoma and pancreatic intraepithelial neoplasia: an immunohistochemical analysis with automated cellular imaging. Am. J. Clin. Pathol. 118, 194–201 (2002).
  Article CAS PubMed Google Scholar
• Tucker, O. N. et al. Cyclooxygenase-2 expression is up-regulated in human pancreatic cancer. Cancer Res. 59, 987–990 (1999).
  CAS PubMed Google Scholar
• Anderson, K. E., Johnson, T. W., Lazovich, D. & Folsom, A. R. Association between nonsteroidal anti-inflammatory drug use and the incidence of pancreatic cancer. J. Natl Cancer Inst. 94, 1168–1171 (2002).
  Article PubMed Google Scholar
• Oshima, M. & Taketo, M. M. COX selectivity and animal models for colon cancer. Curr. Pharm. Des. 8, 1021–1034 (2002).
  Article CAS PubMed Google Scholar
• Ramaswamy, S. & Golub, T. R. DNA microarrays in clinical oncology. J. Clin. Oncol. 20, 1932–1941 (2002).
  Article CAS PubMed Google Scholar
• Argani, P. et al. Discovery of new markers of cancer through serial analysis of gene expression: prostate stem cell antigen is overexpressed in pancreatic adenocarcinoma. Cancer Res. 61, 4320–4324 (2001).
  CAS PubMed Google Scholar
• Iacobuzio-Donahue, C. A. et al. Discovery of novel tumor markers of pancreatic cancer using global gene expression technology. Am. J. Pathol. 160, 1239–1249 (2002).
  Article CAS PubMed PubMed Central Google Scholar
• Rosty, C. et al. Identification of hepatocarcinoma-intestine-pancreas/pancreatitis-associated protein I as a biomarker for pancreatic ductal adenocarcinoma by protein biochip technology. Cancer Res. 62, 1868–1875 (2002).
  CAS PubMed Google Scholar
• Han, H. et al. Identification of differentially expressed genes in pancreatic cancer cells using cDNA microarray. Cancer Res. 62, 2890–2896 (2002).
  CAS PubMed Google Scholar
• Githens, S. in The Pancreas: Biology, Pathobiology and Disease (eds Liang, V. & Go, W.) 21–55 (Raven Press Ltd, New York, 1993).
  Google Scholar
• Slack, J. M. Developmental biology of the pancreas. Development 121, 1569–1580 (1995).
  Article CAS PubMed Google Scholar
• Kim, S. K. & Hebrok, M. Intercellular signals regulating pancreas development and function. Genes Dev. 15, 111–127 (2001).
  Article CAS PubMed Google Scholar
• Kobitsu, K. et al. Shortened telomere length and increased telomerase activity in hamster pancreatic duct adenocarcinomas and cell lines. Mol. Carcinog. 18, 153–159 (1997).
  Article CAS PubMed Google Scholar
• Edlund, H. Organogenesis: pancreatic organogenesis developmental mechanisms and implications for therapy. Nature Rev. Genet. 3, 524–532 (2002).
  Article CAS PubMed Google Scholar
• Hebrok, M., Kim, S. K. & Melton, D. A. Notochord repression of endodermal Sonic hedgehog permits pancreas development. Genes Dev. 12, 1705–1713 (1998).
  Article CAS PubMed PubMed Central Google Scholar
• Wells, J. M. & Melton, D. A. Vertebrate endoderm development. Annu. Rev. Cell Dev. Biol. 15, 393–410 (1999).
  Article CAS PubMed Google Scholar
• Shen, C. N., Slack, J. M. & Tosh, D. Molecular basis of transdifferentiation of pancreas to liver. Nature Cell Biol. 2, 879–887 (2000).
  Article CAS PubMed Google Scholar
• Harada, T. et al. Interglandular cytogenetic heterogeneity detected by comparative genomic hybridization in pancreatic cancer. Cancer Res 62, 835–839 (2002).
  CAS PubMed Google Scholar
• Giardiello, F. M. et al. Very high risk of cancer in familial Peutz–Jeghers syndrome. Gastroenterology 119, 1447–1453 (2000).
  Article CAS PubMed Google Scholar
• Clarke, A. R., Cummings, M. C. & Harrison, D. J. Interaction between murine germline mutations in p53 and APC predisposes to pancreatic neoplasia but not to increased intestinal malignancy. Oncogene 11, 1913–1920 (1995).
  CAS PubMed Google Scholar
• Meszoely, I. M., Means, A. L., Scoggins, C. R. & Leach, S. D. Developmental aspects of early pancreatic cancer. Cancer J. 7, 242–250 (2001).
  CAS PubMed Google Scholar